FERRETTI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 17.515
AS - Asia 8.345
EU - Europa 6.305
SA - Sud America 1.783
AF - Africa 157
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 9
Totale 34.133
Nazione #
US - Stati Uniti d'America 17.209
SG - Singapore 3.424
IT - Italia 2.238
CN - Cina 2.201
BR - Brasile 1.495
HK - Hong Kong 939
UA - Ucraina 935
DE - Germania 930
TR - Turchia 687
GB - Regno Unito 454
VN - Vietnam 447
RU - Federazione Russa 341
SE - Svezia 305
PL - Polonia 286
FI - Finlandia 257
ID - Indonesia 164
MX - Messico 142
FR - Francia 131
CA - Canada 128
AR - Argentina 113
NL - Olanda 109
IN - India 97
AT - Austria 65
BD - Bangladesh 63
ZA - Sudafrica 60
ES - Italia 55
JP - Giappone 52
EC - Ecuador 47
IQ - Iraq 42
BE - Belgio 38
PK - Pakistan 32
VE - Venezuela 31
CO - Colombia 28
IR - Iran 26
PY - Paraguay 26
CZ - Repubblica Ceca 22
UZ - Uzbekistan 20
CH - Svizzera 19
CL - Cile 18
KE - Kenya 18
LT - Lituania 18
MA - Marocco 18
AU - Australia 17
JO - Giordania 15
MY - Malesia 15
KZ - Kazakistan 12
AE - Emirati Arabi Uniti 11
AL - Albania 11
EG - Egitto 11
IE - Irlanda 11
NP - Nepal 11
PE - Perù 11
KR - Corea 10
RO - Romania 10
TN - Tunisia 10
AZ - Azerbaigian 9
EU - Europa 9
RS - Serbia 9
SA - Arabia Saudita 9
IL - Israele 8
SM - San Marino 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
SN - Senegal 7
TW - Taiwan 7
CR - Costa Rica 6
DK - Danimarca 6
DZ - Algeria 6
LB - Libano 6
LV - Lettonia 6
OM - Oman 6
PT - Portogallo 6
UY - Uruguay 6
HN - Honduras 5
HU - Ungheria 5
JM - Giamaica 5
TH - Thailandia 5
BG - Bulgaria 4
CY - Cipro 4
EE - Estonia 4
GH - Ghana 4
HR - Croazia 4
PH - Filippine 4
SI - Slovenia 4
AM - Armenia 3
AO - Angola 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
GE - Georgia 3
GT - Guatemala 3
LU - Lussemburgo 3
LY - Libia 3
NG - Nigeria 3
NO - Norvegia 3
PS - Palestinian Territory 3
SV - El Salvador 3
BB - Barbados 2
BH - Bahrain 2
ET - Etiopia 2
GA - Gabon 2
Totale 34.105
Città #
Fairfield 2.120
Woodbridge 1.928
Singapore 1.831
Ashburn 1.528
Jacksonville 1.116
Houston 1.075
Chandler 945
Hong Kong 933
Seattle 849
Santa Clara 737
Wilmington 725
Cambridge 718
Ann Arbor 696
Beijing 606
Izmir 460
Nanjing 366
Princeton 283
Warsaw 276
Dallas 256
Dearborn 237
Ferrara 213
Milan 201
Los Angeles 178
Ho Chi Minh City 175
San Diego 172
Bremen 162
New York 157
Boardman 137
Rome 132
Munich 124
Jakarta 119
São Paulo 118
Nanchang 105
Mexico City 92
Hanoi 82
Hebei 82
Tianjin 82
Hefei 79
Moscow 76
Falls Church 74
Shenyang 72
Bologna 70
Shanghai 70
Nuremberg 64
London 59
Chicago 54
Changsha 53
Jiaxing 51
Rio de Janeiro 50
Redwood City 48
Mountain View 47
Kunming 46
Buffalo 45
Naples 45
The Dalles 44
Tokyo 41
Belo Horizonte 40
Orange 40
Jinan 39
Turku 39
Brooklyn 37
Columbus 36
Montreal 36
Norwalk 36
Vienna 36
Stockholm 35
Brussels 34
Florence 33
Brasília 32
Johannesburg 32
San Francisco 32
Toronto 32
Atlanta 30
Curitiba 30
Guangzhou 30
Helsinki 30
Zhengzhou 29
Turin 27
Amsterdam 26
Council Bluffs 26
Palermo 25
Boston 24
Frankfurt am Main 24
Haiphong 24
Chennai 22
Guayaquil 22
Ningbo 22
San Mateo 22
St Petersburg 22
Falkenstein 21
Lappeenranta 21
Orem 21
Porto Alegre 21
Ankara 20
Manchester 20
Verona 20
Guarulhos 19
Phoenix 19
Salvador 18
Tashkent 18
Totale 22.326
Nome #
Mixed odontogenic tumors. Studies on the significance of correlations between ameloblastic fibroma, ameloblastic fibro-odontoma and odontoma 530
Classificazione TNM dei tumori maligni-VIII edizione: Quali novità? 487
Protocollo assistenziale nelle donne a rischio ereditario di tumore della mammella e/o ovaio 382
Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) 296
Survival of cancer patients in Europe: the EUROCARE study 266
I tumori in Emilia-Romagna 253
I tumori in Italia, rapporto 2007: sopravvivenza. 250
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 220
Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFα therapy in rheumatoid arthritis? 219
Characteristics of the colorectal cancers diagnosed in the early 2000s in Italy. Figures from the IMPATTO study on colorectal cancer screening [Caratteristiche dei tumori del colon retto diagnosticati in Italia nei primi anni Duemila. Dati dello studio IMPATTO sdelo screening colorettale] 217
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 215
Classificazione Internazionale delle malattie per l'Oncologia, terza edizione 206
Establishment of Keratinocyte Colonies From Small-Sized Cervical Intraepithelial Neoplasia Specimens 195
Time to viral clearance after successful conservative treatment for high-risk HPV-infected high-grade cervical intraepithelial neoplasia and early invasive squamous cervical carcinoma 189
Application of quantitative analysis to biologic profile evaluation in breast cancer 183
Annual mammography at age 45-49 years and biennial mammography at age 50-69 years: comparing performance measures in an organised screening setting 182
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 180
Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: Results from the IMPATTO study 180
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2) 176
Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002 175
The effect of palliative care on the assistance of terminally ill cancer patients in the Province of Ferrara in 2002 172
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts 171
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet - a population-based study 171
Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours 171
Completeness and timeliness: Cancer registries could/should improve their performance 168
Ageing and other factors behind recent cancer incidence and mortality trends in Italy 168
Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy 168
I programmi di screening oncologici in Emilia-Romagna. I dati dei seminari regionali 2016 168
The burden of HPV-related diseases in Italy, 2001-12 166
An estimate of the number of people in Italy living after a childhood cancer 166
Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy 166
Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma 165
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States 164
Rare Ovarian Tumours: Epidemiology, Treatment Challenges in and outside a Network Setting 164
Registro Tumori della provincia di Ferrara 163
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries 163
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2) 160
Survival from salivary glands adenoid cystic carcinoma in European populations 160
A simple method to estimate the episode and programme sensitivity of breast cancer screening programmes 160
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project 159
Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89828 children from 198 registries in 53 countries 159
Interpretation of colposcopy in population-based cervical screening services in north-eastern Italy: an online interregional agreement study 158
Epidemiology of rare cancers and inequalities in oncologic outcomes 158
Il protocollo Diagnostico-Terapeutico e Assistenziale per il carcinoma mammario della Regione Emilia-Romagna. I edizione 156
International incidence of childhood cancer, 2001-10: a population-based registry study 154
Italy, Ferrara province 153
Contribution of cell kinetics with Ki-67 to the biopathological and prognostic characterization of breast cancer 153
Quantitative immunoprofiles of breast cancer performed by image analysis 152
p53 Expression in colorectal cancer: Relation to tumor type, DNA ploidy pattern, and short-term survival 150
Il problema dei tumori in provincia di Ferrara: incidenza, mortalità e prospettive terapeutiche 149
Treatment challenges in and outside a network setting: Soft tissue sarcomas 149
Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression 148
Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy 148
The Results of an Italian Quality Assurance Program Support the New American Society for Colposcopy and Cervical Pathology Recommendations for Colposcopy Practice 148
Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study 147
Estimates of cancer burden in Emilia-Romagna 147
Classificazione TNM dei tumori maligni, VII edizione 2009. Novità e ricadute pratiche per l’epidemiologia dei tumori. 147
Early (short-interval) rescreen in mammography screening 146
Long-term survival, prevalence, and cure of cancer: A population-based estimation for 818,902 Italian patients and 26 cancer types 146
BRCA1 LOH and biological profile of breast cancer. Comparison between two age groups. 145
The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project. 144
Biological profile of breast carcinoma in situ investigated by immunohistochemical technique 143
Cancer prevalence estimates in Europe at the beginning of 2000 143
Indicatori e valori di riferimento nella valutazione della ploidia del carcinoma mammario 142
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 142
I tumori in Italia - Rapporto 2012. I tumori dei bambini e degli adolescenti [Italian cancer figures, report 2012: Cancer in children and adolescents] 141
Coping with problems that flaw the estimate of mammography sensitivity in population-based screening programmes: the Italian perspective 140
[The contribution of the Italian association of cancer registries (AIRTUM)] 140
The burden of rare cancers in Europe 140
Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects 139
Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe 139
Population-based method for investigating adherence to international recommendations for pathology reporting of primary cutaneous melanoma: Results of a EUROCARE-5 high resolution study 139
National estimates of cancer patients survival in italy: A model-based method 138
Screening history of cervical cancers in Emilia-Romagna, Italy: defining priorities to improve cervical cancer screening 138
Incidence and survival trends of cervical adenocarcinoma in Italy: Cytology screening has become more effective in downstaging the disease but not in detecting its precursors 138
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the " Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 138
The advantage of women in cancer survival: An analysis of EUROCARE-4 data 137
Incidence trends of colorectal cancer in the early 2000s in Italy. Figures from the IMPATTO study on colorectal cancer screening 137
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe 136
Regional inequalities in cancer care persist in Italy and can influence survival 136
Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study 136
Incidence, survival and prevalence of myeloid malignancies in Europe 135
Survival of European patients with central nervous system tumors 135
Rare cancers of the head and neck area in Europe 135
Cancer Incidence in Ferrara Province (1998-2002) 135
The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods 135
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study 135
Cancer incidence and mortality trends from 2003 to 2014 in Italy 135
Aggiornamento della sopravvivenza dei pazienti con tumore in Italia: confronti geografici e focus su pazienti con tumori oggetto di screening, pediatrici e associati al fumo [Update of survival of cancer patients in Italy: geographical comparisons and focus on patients with cancers targeted by screening programmes, childhood cancers, and smoking-associated cancers] 134
Rare cancers are not so rare: the rare cancer burden in Europe 134
Methodological aspects of estimating rare cancer prevalence in Europe: The experience of the RARECARE project 134
Changes in cervical cancer incidence following the introduction of organized screening in Italy 134
AIRTUM e SIE insieme per una definizione condivisa dei tumori emolinfopoietici [AIRTUM and SIE for a shared definition of haemolymphopoietic cancers] 134
The cure of cancer: A European perspective 134
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: Results of EUROCARE-5, a population-based study 134
Estimates of cancer burden in Italy 133
Incidence and survival of rare urogenital cancers in Europe 133
Breast screening: axillary lymph node status of interval cancers by interval year 132
Cancer incidence and mortality in the province of Ferrara 1989-1990 132
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002 131
Totale 16.797
Categoria #
all - tutte 171.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.081
Totale 177.335


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.076 0 0 0 0 0 313 155 415 179 410 366 238
2021/20222.548 87 295 205 166 129 144 134 195 109 203 188 693
2022/20232.580 312 127 52 266 488 379 61 253 328 34 170 110
2023/20241.426 170 169 60 75 99 125 61 74 44 67 90 392
2024/20255.931 208 147 527 191 728 427 366 401 889 777 686 584
2025/20267.440 1.230 661 1.483 1.800 1.860 406 0 0 0 0 0 0
Totale 34.662